GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea · Delayed Price · Currency is KRW 14,300
+10 (0.07%)
At close: Aug 4, 2025, 3:30 PM KST
GFC Life Science Revenue
In the year 2021, GFC Life Science had annual revenue of 13.74B KRW with 3.09% growth.
Revenue
13.74B
Revenue Growth
+3.09%
P/S Ratio
5.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 13.74B | 412.37M | 3.09% |
| Dec 31, 2020 | 13.32B | 1.42B | 11.89% |
| Dec 31, 2019 | 11.91B | 3.23B | 37.21% |
| Dec 31, 2018 | 8.68B | 1.52B | 21.20% |
| Dec 31, 2017 | 7.16B | 154.44M | 2.20% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| Doosan Enerbility | 15.88T |